According to Onconova Therapeutics's latest financial reports the company's current EPS (TTM) is -0,81ย โฌ. In 2014 the company made an earnings per share (EPS) of -5.652ย โฌ an increase over its 2013 EPS that were of -7.102ย โฌ.